The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point-of-Care Testing (POCT) Market Outlook 2024

Global Point-of-Care Testing (POCT) Market Outlook 2024

Publishing Date : Dec, 2021

License Type :
 

Report Code : 1656108

No of Pages : 134

Synopsis
Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

The global Point-of-Care Testing (POCT) market was valued at US$ 23460 million in 2020 and is expected to reach US$ 44000 million by the end of 2027, growing at a CAGR of 9.4% during 2021-2027.
This report focuses on Point-of-Care Testing (POCT) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Point-of-Care Testing (POCT) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Point-of-Care Testing (POCT) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing

Segment by Application
Clinics
Hospitals
Laboratory
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
Index
1 Point-of-Care Testing (POCT) Market Overview
1.1 Product Overview and Scope of Point-of-Care Testing (POCT)
1.2 Point-of-Care Testing (POCT) Segment by Type
1.2.1 Global Point-of-Care Testing (POCT) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.3 Point-of-Care Testing (POCT) Segment by Application
1.3.1 Global Point-of-Care Testing (POCT) Sales Comparison by Application: (2021-2027)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts
1.4.1 Global Point-of-Care Testing (POCT) Revenue 2016-2027
1.4.2 Global Point-of-Care Testing (POCT) Sales 2016-2027
1.4.3 Point-of-Care Testing (POCT) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Point-of-Care Testing (POCT) Market Competition by Manufacturers
2.1 Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Point-of-Care Testing (POCT) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Point-of-Care Testing (POCT) Manufacturing Sites, Area Served, Product Type
2.5 Point-of-Care Testing (POCT) Market Competitive Situation and Trends
2.5.1 Point-of-Care Testing (POCT) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Point-of-Care Testing (POCT) Players Market Share by Revenue
2.5.3 Global Point-of-Care Testing (POCT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Point-of-Care Testing (POCT) Retrospective Market Scenario by Region
3.1 Global Point-of-Care Testing (POCT) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Point-of-Care Testing (POCT) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Point-of-Care Testing (POCT) Market Facts & Figures by Country
3.3.1 North America Point-of-Care Testing (POCT) Sales by Country
3.3.2 North America Point-of-Care Testing (POCT) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Point-of-Care Testing (POCT) Market Facts & Figures by Country
3.4.1 Europe Point-of-Care Testing (POCT) Sales by Country
3.4.2 Europe Point-of-Care Testing (POCT) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Point-of-Care Testing (POCT) Market Facts & Figures by Region
3.5.1 Asia Pacific Point-of-Care Testing (POCT) Sales by Region
3.5.2 Asia Pacific Point-of-Care Testing (POCT) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Point-of-Care Testing (POCT) Market Facts & Figures by Country
3.6.1 Latin America Point-of-Care Testing (POCT) Sales by Country
3.6.2 Latin America Point-of-Care Testing (POCT) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Point-of-Care Testing (POCT) Market Facts & Figures by Country
3.7.1 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country
3.7.2 Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Point-of-Care Testing (POCT) Historic Market Analysis by Type
4.1 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2016-2021)
4.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2016-2021)
4.3 Global Point-of-Care Testing (POCT) Price by Type (2016-2021)

5 Global Point-of-Care Testing (POCT) Historic Market Analysis by Application
5.1 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2016-2021)
5.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2016-2021)
5.3 Global Point-of-Care Testing (POCT) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Corporation Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Ascensia
6.6.1 Ascensia Corporation Information
6.6.2 Ascensia Description and Business Overview
6.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
6.6.5 Ascensia Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 BioMerieux
6.8.1 BioMerieux Corporation Information
6.8.2 BioMerieux Description and Business Overview
6.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
6.8.5 BioMerieux Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 Nova Biomedical
6.10.1 Nova Biomedical Corporation Information
6.10.2 Nova Biomedical Description and Business Overview
6.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.10.5 Nova Biomedical Recent Developments/Updates
6.11 Trividia Health
6.11.1 Trividia Health Corporation Information
6.11.2 Trividia Health Point-of-Care Testing (POCT) Description and Business Overview
6.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
6.11.5 Trividia Health Recent Developments/Updates
6.12 Quidel
6.12.1 Quidel Corporation Information
6.12.2 Quidel Point-of-Care Testing (POCT) Description and Business Overview
6.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
6.12.5 Quidel Recent Developments/Updates
6.13 Accriva
6.13.1 Accriva Corporation Information
6.13.2 Accriva Point-of-Care Testing (POCT) Description and Business Overview
6.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
6.13.5 Accriva Recent Developments/Updates
6.14 OraSure Technologies
6.14.1 OraSure Technologies Corporation Information
6.14.2 OraSure Technologies Point-of-Care Testing (POCT) Description and Business Overview
6.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
6.14.5 OraSure Technologies Recent Developments/Updates
6.15 Helena Laboratories
6.15.1 Helena Laboratories Corporation Information
6.15.2 Helena Laboratories Point-of-Care Testing (POCT) Description and Business Overview
6.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
6.15.5 Helena Laboratories Recent Developments/Updates
6.16 A. Menarini Diagnostics
6.16.1 A. Menarini Diagnostics Corporation Information
6.16.2 A. Menarini Diagnostics Point-of-Care Testing (POCT) Description and Business Overview
6.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.16.5 A. Menarini Diagnostics Recent Developments/Updates
6.17 Abaxis (Zoetis)
6.17.1 Abaxis (Zoetis) Corporation Information
6.17.2 Abaxis (Zoetis) Point-of-Care Testing (POCT) Description and Business Overview
6.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
6.17.5 Abaxis (Zoetis) Recent Developments/Updates
6.18 Ortho Clinical Diagnostics
6.18.1 Ortho Clinical Diagnostics Corporation Information
6.18.2 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Description and Business Overview
6.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.18.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.19 Phamatech
6.19.1 Phamatech Corporation Information
6.19.2 Phamatech Point-of-Care Testing (POCT) Description and Business Overview
6.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
6.19.5 Phamatech Recent Developments/Updates
6.20 Chembio Diagnostics
6.20.1 Chembio Diagnostics Corporation Information
6.20.2 Chembio Diagnostics Point-of-Care Testing (POCT) Description and Business Overview
6.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
6.20.5 Chembio Diagnostics Recent Developments/Updates
6.21 Trinity Biotech
6.21.1 Trinity Biotech Corporation Information
6.21.2 Trinity Biotech Point-of-Care Testing (POCT) Description and Business Overview
6.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
6.21.5 Trinity Biotech Recent Developments/Updates
6.22 ELITech Group
6.22.1 ELITech Group Corporation Information
6.22.2 ELITech Group Point-of-Care Testing (POCT) Description and Business Overview
6.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
6.22.5 ELITech Group Recent Developments/Updates
6.23 Response Biomedical
6.23.1 Response Biomedical Corporation Information
6.23.2 Response Biomedical Point-of-Care Testing (POCT) Description and Business Overview
6.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
6.23.5 Response Biomedical Recent Developments/Updates
6.24 Princeton BioMeditech
6.24.1 Princeton BioMeditech Corporation Information
6.24.2 Princeton BioMeditech Point-of-Care Testing (POCT) Description and Business Overview
6.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
6.24.5 Princeton BioMeditech Recent Developments/Updates
6.25 Alfa Wassermann
6.25.1 Alfa Wassermann Corporation Information
6.25.2 Alfa Wassermann Point-of-Care Testing (POCT) Description and Business Overview
6.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
6.25.5 Alfa Wassermann Recent Developments/Updates

7 Point-of-Care Testing (POCT) Manufacturing Cost Analysis
7.1 Point-of-Care Testing (POCT) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Point-of-Care Testing (POCT)
7.4 Point-of-Care Testing (POCT) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Point-of-Care Testing (POCT) Distributors List
8.3 Point-of-Care Testing (POCT) Customers

9 Point-of-Care Testing (POCT) Market Dynamics
9.1 Point-of-Care Testing (POCT) Industry Trends
9.2 Point-of-Care Testing (POCT) Growth Drivers
9.3 Point-of-Care Testing (POCT) Market Challenges
9.4 Point-of-Care Testing (POCT) Market Restraints

10 Global Market Forecast
10.1 Point-of-Care Testing (POCT) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Point-of-Care Testing (POCT) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Point-of-Care Testing (POCT) by Type (2022-2027)
10.2 Point-of-Care Testing (POCT) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Point-of-Care Testing (POCT) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Point-of-Care Testing (POCT) by Application (2022-2027)
10.3 Point-of-Care Testing (POCT) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Point-of-Care Testing (POCT) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Point-of-Care Testing (POCT) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Point-of-Care Testing (POCT) Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Point-of-Care Testing (POCT) Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Point-of-Care Testing (POCT) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Point-of-Care Testing (POCT) Covered in This Study
Table 5. Global Point-of-Care Testing (POCT) Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Point-of-Care Testing (POCT) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Point-of-Care Testing (POCT) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Point-of-Care Testing (POCT) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Point-of-Care Testing (POCT) Manufacturing Sites and Area Served
Table 11. Manufacturers Point-of-Care Testing (POCT) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Testing (POCT) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Point-of-Care Testing (POCT) Sales by Region (2016-2021) & (M Units)
Table 16. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2016-2021)
Table 17. Global Point-of-Care Testing (POCT) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Point-of-Care Testing (POCT) Sales by Country (2016-2021) & (M Units)
Table 19. North America Point-of-Care Testing (POCT) Sales Market Share by Country (2016-2021)
Table 20. North America Point-of-Care Testing (POCT) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Point-of-Care Testing (POCT) Revenue Market Share by Country (2016-2021)
Table 22. Europe Point-of-Care Testing (POCT) Sales by Country (2016-2021) & (M Units)
Table 23. Europe Point-of-Care Testing (POCT) Sales Market Share by Country (2016-2021)
Table 24. Europe Point-of-Care Testing (POCT) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Point-of-Care Testing (POCT) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Point-of-Care Testing (POCT) Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Point-of-Care Testing (POCT) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Point-of-Care Testing (POCT) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Point-of-Care Testing (POCT) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Point-of-Care Testing (POCT) Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Point-of-Care Testing (POCT) Sales Market Share by Country (2016-2021)
Table 32. Latin America Point-of-Care Testing (POCT) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Point-of-Care Testing (POCT) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Point-of-Care Testing (POCT) Revenue Market Share by Country (2016-2021)
Table 38. Global Point-of-Care Testing (POCT) Sales (M Units) by Type (2016-2021)
Table 39. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2016-2021)
Table 40. Global Point-of-Care Testing (POCT) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Point-of-Care Testing (POCT) Revenue Share by Type (2016-2021)
Table 42. Global Point-of-Care Testing (POCT) Price (USD/Unit) by Type (2016-2021)
Table 43. Global Point-of-Care Testing (POCT) Sales (M Units) by Application (2016-2021)
Table 44. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2016-2021)
Table 45. Global Point-of-Care Testing (POCT) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Point-of-Care Testing (POCT) Revenue Share by Application (2016-2021)
Table 47. Global Point-of-Care Testing (POCT) Price (USD/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Roche Point-of-Care Testing (POCT) Product
Table 52. Roche Recent Developments/Updates
Table 53. Abbott Corporation Information
Table 54. Abbott Description and Business Overview
Table 55. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Abbott Point-of-Care Testing (POCT) Product
Table 57. Abbott Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Point-of-Care Testing (POCT) Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Siemens Healthcare Corporation Information
Table 64. Siemens Healthcare Description and Business Overview
Table 65. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Siemens Healthcare Point-of-Care Testing (POCT) Product
Table 67. Siemens Healthcare Recent Developments/Updates
Table 68. Danaher Corporation Information
Table 69. Danaher Description and Business Overview
Table 70. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Danaher Point-of-Care Testing (POCT) Product
Table 72. Danaher Recent Developments/Updates
Table 73. Ascensia Corporation Information
Table 74. Ascensia Description and Business Overview
Table 75. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Ascensia Point-of-Care Testing (POCT) Product
Table 77. Ascensia Recent Developments/Updates
Table 78. Bio-Rad Laboratories Corporation Information
Table 79. Bio-Rad Laboratories Description and Business Overview
Table 80. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product
Table 82. Bio-Rad Laboratories Recent Developments/Updates
Table 83. BioMerieux Corporation Information
Table 84. BioMerieux Description and Business Overview
Table 85. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. BioMerieux Point-of-Care Testing (POCT) Product
Table 87. BioMerieux Recent Developments/Updates
Table 88. ARKRAY Corporation Information
Table 89. ARKRAY Description and Business Overview
Table 90. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. ARKRAY Point-of-Care Testing (POCT) Product
Table 92. ARKRAY Recent Developments/Updates
Table 93. Nova Biomedical Corporation Information
Table 94. Nova Biomedical Description and Business Overview
Table 95. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Nova Biomedical Point-of-Care Testing (POCT) Product
Table 97. Nova Biomedical Recent Developments/Updates
Table 98. Trividia Health Corporation Information
Table 99. Trividia Health Description and Business Overview
Table 100. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Trividia Health Point-of-Care Testing (POCT) Product
Table 102. Trividia Health Recent Developments/Updates
Table 103. Quidel Corporation Information
Table 104. Quidel Description and Business Overview
Table 105. Quidel Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Quidel Point-of-Care Testing (POCT) Product
Table 107. Quidel Recent Developments/Updates
Table 108. Accriva Corporation Information
Table 109. Accriva Description and Business Overview
Table 110. Accriva Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Accriva Point-of-Care Testing (POCT) Product
Table 112. Accriva Recent Developments/Updates
Table 113. OraSure Technologies Corporation Information
Table 114. OraSure Technologies Description and Business Overview
Table 115. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. OraSure Technologies Point-of-Care Testing (POCT) Product
Table 117. OraSure Technologies Recent Developments/Updates
Table 118. Helena Laboratories Corporation Information
Table 119. Helena Laboratories Description and Business Overview
Table 120. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Helena Laboratories Point-of-Care Testing (POCT) Product
Table 122. Helena Laboratories Recent Developments/Updates
Table 123. A. Menarini Diagnostics Corporation Information
Table 124. A. Menarini Diagnostics Description and Business Overview
Table 125. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product
Table 127. A. Menarini Diagnostics Recent Developments/Updates
Table 128. Abaxis (Zoetis) Corporation Information
Table 129. Abaxis (Zoetis) Description and Business Overview
Table 130. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product
Table 132. Abaxis (Zoetis) Recent Developments/Updates
Table 133. Ortho Clinical Diagnostics Corporation Information
Table 134. Ortho Clinical Diagnostics Description and Business Overview
Table 135. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product
Table 137. Ortho Clinical Diagnostics Recent Developments/Updates
Table 138. Phamatech Corporation Information
Table 139. Phamatech Description and Business Overview
Table 140. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Phamatech Point-of-Care Testing (POCT) Product
Table 142. Phamatech Recent Developments/Updates
Table 143. Chembio Diagnostics Corporation Information
Table 144. Chembio Diagnostics Description and Business Overview
Table 145. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Chembio Diagnostics Point-of-Care Testing (POCT) Product
Table 147. Chembio Diagnostics Recent Developments/Updates
Table 148. Trinity Biotech Corporation Information
Table 149. Trinity Biotech Description and Business Overview
Table 150. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Trinity Biotech Point-of-Care Testing (POCT) Product
Table 152. Trinity Biotech Recent Developments/Updates
Table 153. ELITech Group Corporation Information
Table 154. ELITech Group Description and Business Overview
Table 155. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. ELITech Group Point-of-Care Testing (POCT) Product
Table 157. ELITech Group Recent Developments/Updates
Table 158. Response Biomedical Corporation Information
Table 159. Response Biomedical Description and Business Overview
Table 160. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. Response Biomedical Point-of-Care Testing (POCT) Product
Table 162. Response Biomedical Recent Developments/Updates
Table 163. Princeton BioMeditech Corporation Information
Table 164. Princeton BioMeditech Description and Business Overview
Table 165. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 166. Princeton BioMeditech Point-of-Care Testing (POCT) Product
Table 167. Princeton BioMeditech Recent Developments/Updates
Table 168. Alfa Wassermann Corporation Information
Table 169. Alfa Wassermann Description and Business Overview
Table 170. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 171. Alfa Wassermann Point-of-Care Testing (POCT) Product
Table 172. Alfa Wassermann Recent Developments/Updates
Table 173. Production Base and Market Concentration Rate of Raw Material
Table 174. Key Suppliers of Raw Materials
Table 175. Point-of-Care Testing (POCT) Distributors List
Table 176. Point-of-Care Testing (POCT) Customers List
Table 177. Point-of-Care Testing (POCT) Market Trends
Table 178. Point-of-Care Testing (POCT) Growth Drivers
Table 179. Point-of-Care Testing (POCT) Market Challenges
Table 180. Point-of-Care Testing (POCT) Market Restraints
Table 181. Global Point-of-Care Testing (POCT) Sales Forecast by Type (2022-2027) & (M Units)
Table 182. Global Point-of-Care Testing (POCT) Sales Market Share Forecast by Type (2022-2027)
Table 183. Global Point-of-Care Testing (POCT) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 184. Global Point-of-Care Testing (POCT) Revenue Market Share Forecast by Type (2022-2027)
Table 185. Global Point-of-Care Testing (POCT) Sales Forecast by Application (2022-2027) & (M Units)
Table 186. Global Point-of-Care Testing (POCT) Sales Market Share Forecast by Application (2022-2027)
Table 187. Global Point-of-Care Testing (POCT) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 188. Global Point-of-Care Testing (POCT) Revenue Market Share Forecast by Application (2022-2027)
Table 189. Global Point-of-Care Testing (POCT) Sales Forecast by Region (2022-2027) & (M Units)
Table 190. Global Point-of-Care Testing (POCT) Sales Market Share Forecast by Region (2022-2027)
Table 191. Global Point-of-Care Testing (POCT) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 192. Global Point-of-Care Testing (POCT) Revenue Market Share Forecast by Region (2022-2027)
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Point-of-Care Testing (POCT)
Figure 2. Global Point-of-Care Testing (POCT) Market Share by Type in 2020 & 2027
Figure 3. Blood Glucose Testing Product Picture
Figure 4. Infectious Diseases Testing Product Picture
Figure 5. Cardiac Markers Testing Product Picture
Figure 6. Coagulation Testing Product Picture
Figure 7. Pregnancy and Fertility Testing Product Picture
Figure 8. Blood Gas/Electrolytes Testing Product Picture
Figure 9. Urinalysis Testing Product Picture
Figure 10. Global Point-of-Care Testing (POCT) Market Share by Application in 2020 & 2027
Figure 11. Clinics
Figure 12. Hospitals
Figure 13. Laboratory
Figure 14. Others
Figure 15. Global Point-of-Care Testing (POCT) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Point-of-Care Testing (POCT) Market Size 2016-2027 (US$ Million)
Figure 17. Global Point-of-Care Testing (POCT) Sales 2016-2027 (M Units)
Figure 18. Global Point-of-Care Testing (POCT) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Point-of-Care Testing (POCT) Sales Share by Manufacturers in 2020
Figure 20. Global Point-of-Care Testing (POCT) Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Point-of-Care Testing (POCT) Players: Market Share by Revenue in 2020
Figure 22. Point-of-Care Testing (POCT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2016-2021)
Figure 24. Global Point-of-Care Testing (POCT) Sales Market Share by Region in 2020
Figure 25. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2016-2021)
Figure 26. Global Point-of-Care Testing (POCT) Revenue Market Share by Region in 2020
Figure 27. U.S. Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. China Taiwan Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Point-of-Care Testing (POCT) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Point-of-Care Testing (POCT) by Type (2016-2021)
Figure 50. Sales Market Share of Point-of-Care Testing (POCT) by Application (2016-2021)
Figure 51. Sales Market Share of Point-of-Care Testing (POCT) by Application in 2020
Figure 52. Revenue Share of Point-of-Care Testing (POCT) by Application (2016-2021)
Figure 53. Revenue Share of Point-of-Care Testing (POCT) by Application in 2020
Figure 54. Manufacturing Cost Structure of Point-of-Care Testing (POCT)
Figure 55. Manufacturing Process Analysis of Point-of-Care Testing (POCT)
Figure 56. Point-of-Care Testing (POCT) Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’